Home › Studies › PRJNA1255639
PRJNA1255639 SRP581371

Gut microbiota in sepsis vs non-sepsis, Brazil (case-control)

Gut microbiota of SIRS and sepsis patients

89 stool samples (51 non-sepsis, 38 sepsis) from critically ill patients in Rio Grande do Sul, Brazil, analyzed by 16S rRNA sequencing to compare gut microbiota between sepsis and non-sepsis cases; case-control design. machine-written summary

89 samples · 89 runs · BR · Age unknown · 2026 · 0.16 Gbp / sample

Sources
✓Sequence archive 534✓Abstract / description 90✓Full text 89✓Supplementary tables 352–External resources–User contribution–Human verified

Checked this project's papers and archive records yourself? Mark it human-verified.

what each source gave
✓ Sequence archive534 sample values (collection date, country, latitude, location region, longitude, subject id)
✓ Abstract / description90 sample values (antibiotic exposure, health condition detail)
✓ Full text89 sample values (location locality) · PMC12411461
✓ Supplementary tables352 sample values (age, health condition, health condition detail, sex)
– External resourcesnot covered by the external resources we ingest
– User contributionnothing uploaded yet
– Human verifiednot yet checked by a person · I checked this project — verify it
Samples at a glance
1 sampling locations · 1 country
Age
adult42
elderly40
unknown7
Condition
other_disease50
other_infection38
Sex
male45
female43
Country
BR89
Body site
primary89
Collected 2022–2023
2022: 30 samples2023: 59 samples20222023
Sequencing depth per sample · this project all projects
all projects, 0–0.03 Gbp: 25,080 samples (4 %)all projects, 0.03–0.1 Gbp: 17,066 samples (3 %)this project, 0.03–0.1 Gbp: 2 samplesall projects, 0.1–0.3 Gbp: 29,179 samples (5 %)this project, 0.1–0.3 Gbp: 86 samplesall projects, 0.3–1 Gbp: 47,044 samples (8 %)this project, 0.3–1 Gbp: 1 samplesall projects, 1–3 Gbp: 124,983 samples (22 %)all projects, 3–10 Gbp: 253,728 samples (44 %)all projects, 10–30 Gbp: 72,533 samples (13 %)all projects, 30–100 Gbp: 3,024 samples (1 %)all projects, 100–300 Gbp: 106 samples (0 %)all projects, ≥ 300 Gbp: 9 samples (0 %)project median 0.16 Gbp per sample0130Gbp
Community composition

No Sandpiper profile for this project's samples yet.

Field coverage
fieldsamplescoverageR1R2R3R4
age_category82 92%
country89 100%89
health_condition88 99%88
subject_id89 100%89
antibiotic_exposure89 100%89
collection_date89 100%89
detailed_location89 100%
health_condition_detail89 100%881
latitude89 100%89
location_locality89 100%89
location_region89 100%89
longitude89 100%89
age_at_collection_days88 99%88
sex88 99%88
Papers (1)
  • Microbial diversity and composition in the gut microbiome of patients during systemic inflammatory response syndrome: can we use gut bacteria as potential biomarkers to characterize sepsis? 2025 PMID 40918250 PMC12411461 own_data
Details
Archive description

Critically ill patients, including those with systemic inflammatory response syndrome (SIRS) and sepsis, often show altered gut microbiota due to physiological stress and the use of broad-spectrum antibiotics. Although antibiotics are essential for treating infections, they can disrupt the gut microbial balance, potentially worsening patient outcomes. Understanding these changes may help guide microbiota-based interventions to reduce antibiotic-associated harm. This study aimed to identify specific bacterial taxa that distinguish sepsis from non-sepsis cases. A total of 89 stool samples (51 non-sepsis, 38 sepsis) were analyzed to assess microbial diversity and detect differentially abundant taxa using 16S rRNA gene sequencing.

How this project entered the registry

Classified as human gut / stool shotgun DNA metagenome of age unknown by sonnet_x2 with confidence 0.60. Assay shotgun_dna.

  • host run.host_tax_id · “9606”
  • body site run.scientific_name · “gut metagenome”
Evidence examples (one per field × route)
samplefieldvaluerouteconf.sourcequote
SAMN48151731age_at_collection_days22280.2R20.80paper.supp.DataSheet1.docx[table2!Age]R001A: Age=61
SAMN48151731antibiotic_exposureyesR40.50study.descriptionuse of broad-spectrum antibiotics
SAMN48151731collection_date2022-08-25R10.90biosample.attribute:collection_date2022-08-25
SAMN48151731countryBRR10.90sample.attr.geo_loc_nameBrazil: Rio Grande do Sul
SAMN48151731health_conditionother_diseaseR20.80paper.supp.DataSheet1.docx[table2!Outcome]R001A: Outcome=no_sepsis
SAMN48151731health_condition_detailnon-sepsis SIRS patientR20.80paper.supp.DataSheet1.docx[table2!Outcome]R001A: Outcome=no_sepsis
SAMN48151739health_condition_detailmixed_case_control: sepsis patients vs non-sepsis (SIRS) patientsR40.50study.descriptionsepsis from non-sepsis cases
SAMN48151731latitude-30.0328R10.90biosample.attribute:lat_lon30.032778 S 51.23 W
SAMN48151731location_localityPorto AlegreR30.70paper.fulltext.methodsHospital de Clínicas de Porto Alegre (HCPA)
SAMN48151731location_regionRio Grande do SulR10.85biosample.attribute:geo_loc_nameBrazil: Rio Grande do Sul
SAMN48151731longitude-51.2300R10.90biosample.attribute:lat_lon30.032778 S 51.23 W
SAMN48151731sexfemaleR20.80paper.supp.DataSheet1.docx[table2!Sex]R001A: Sex=F
SAMN48151731subject_idpatient_1R10.85biosample.attribute:DESCRIPTIONpatient_1
Sequencing

89 runs over 89 samples · mean 0.16 Gbp per run (median 0.16 Gbp, total 14.12 Gbp; 89 runs with a base count) · layout PAIRED 89 · platform ILLUMINA 89 · models Illumina MiSeq (89) · 0% of runs with a Sandpiper profile · first public 2026-06-01

Authors (17)

Ramalho Guerra R first · da Silva Fernandes P · von Ameln Lovison O · de Ross Forni G · Silva de Oliveira G · Viana LC · Castro Pereira D · Latosinski Matos W · Melo Silveira Moretti M · Zempulski Volpato F · Giordani L · Orlandi Barth P · Vieceli T · Rodrigues Falci D · Manozzo Boniatti M · Barth AL · Martins AF last

Downloads

PRJNA1255639.csv.gz (4.0 KB) · parquet (76.1 KB) — all 89 samples, every field with route and confidence · PRJNA1255639_determinations.csv.gz (9.5 KB) — 1,065 evidence rows

Samples (89 · every field this project has values for · hover a cell for its source)
Loading the sample table…